• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

1,095
79
60
57
47

COUNTRY

55
17
8
6
5

CATEGORIES

  • 82
  • 121
  • 66
  • 66
  • 36
  • 37
  • 12
  • 11
  • 12
  • 18

PRICE

548
813
1,673
2,603

PUBLISHED

195
291
746
2,603

PRODUCT TYPE

2,454
74
62
12
1

Oncology

The American Cancer Society forecasts that 1,638,910 new cancer cases will occur in the United States in 2012. As cancer rates worldwide are increasing, the oncological sector of the pharmaceutical industry is growing fast and it will continue to provide business opportunities in the next years. However, cancer trials are some of the most complex, time consuming and expensive across all therapeutic areas. What are the new paths to success in this lucrative but challenging market?

Find out the answer in the reports, books, and subscriptions listed under Research and Markets’ Oncology category. Our top-quality publications from industry experts cover every aspect of cancer drug therapy, with a focus on: Lung Cancer, Breast Cancer, Prostate Cancer, Leukaemia, Lymphoma, Ovarian Cancer, Colon Cancer, Cervical Cancer, Brain Cancer and Bladder Cancer. So read on for the latest clinical trials, pipeline reviews, industry news, and commercial opportunities.

Key players featured in our publications include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis, Wyeth, and many more. Show Less
Read more

PRODUCT TITLE
Proteins in Oncology: Drug Pathway Analyzer 2015 Proteins in Oncology: Drug Pathway Analyzer 2015 - Product Thumbnail Image

Proteins in Oncology: Drug Pathway Analyzer 2015

Extra value: One year of free online updates included with this product There are today at least 365 protein drugs known to affect more than 202 specific intracellular signaling pathways for the treatment...

January 2015
FROM
Conjugated Drugs in Oncology: Drug Pathway Analyzer 2015 Conjugated Drugs in Oncology: Drug Pathway Analyzer 2015 - Product Thumbnail Image

Conjugated Drugs in Oncology: Drug Pathway Analyzer 2015

Extra value: One year of free online updates included with this product There are today at least 306 conjugated drugs known to affect more than 209 specific intracellular signaling pathways for the...

January 2015
FROM
Immunotherapy in Oncology: Drug Pathway Analyzer 2015 Immunotherapy in Oncology: Drug Pathway Analyzer 2015 - Product Thumbnail Image

Immunotherapy in Oncology: Drug Pathway Analyzer 2015

Extra value: One year of free online updates included with this product There are today at least 906 immunotherapy drugs known to affect more than 235 specific intracellular signaling pathways for...

January 2015
FROM
Lung Cancer Drug Pathway Analyzer 2015 Lung Cancer Drug Pathway Analyzer 2015 - Product Thumbnail Image

Lung Cancer Drug Pathway Analyzer 2015

Extra value: One year of free online updates included with this product There are today at least 548 targeted molecular therapies known to affect more than 257 specific intracellular signaling pathways...

January 2015
FROM
Nucleic Acid Therapies in Oncology: Drug Pathway Analyzer 2015 Nucleic Acid Therapies in Oncology: Drug Pathway Analyzer 2015 - Product Thumbnail Image

Nucleic Acid Therapies in Oncology: Drug Pathway Analyzer 2015

Extra value: One year of free online updates included with this product There are today at least 303 nucleic acid drugs known to affect more than 223 specific intracellular signaling pathways for the...

January 2015
FROM
Antibodies in Oncology: Drug Pathway Analyzer 2015 Antibodies in Oncology: Drug Pathway Analyzer 2015 - Product Thumbnail Image

Antibodies in Oncology: Drug Pathway Analyzer 2015

Extra value: One year of free online updates included with this product There are today at least 701 antibody drugs known to affect more than 213 specific intracellular signaling pathways for the treatment...

January 2015
FROM
Biologicals in Oncology: Drug Pathway Analyzer 2015 Biologicals in Oncology: Drug Pathway Analyzer 2015 - Product Thumbnail Image

Biologicals in Oncology: Drug Pathway Analyzer 2015

Extra value: One year of free online updates included with this product There are today at least 1582 biological drugs known to affect more than 268 specific intracellular signaling pathways for the...

January 2015
FROM
Peptides in Oncology: Drug Pathway Analyzer 2015 Peptides in Oncology: Drug Pathway Analyzer 2015 - Product Thumbnail Image

Peptides in Oncology: Drug Pathway Analyzer 2015

Extra value: One year of free online updates included with this product There are today at least 206 peptide drugs known to affect more than 217 specific intracellular signaling pathways for the treatment...

January 2015
FROM
RNAs (miRNA, RNAi & siRNA) in Oncology: Drug Pathway Analyzer 2015 RNAs (miRNA, RNAi & siRNA) in Oncology: Drug Pathway Analyzer 2015 - Product Thumbnail Image

RNAs (miRNA, RNAi & siRNA) in Oncology: Drug Pathway Analyzer 2015

Extra value: One year of free online updates included with this product There are today at least 67 RNA (miRNA, RNAi & siRNA) drugs known to affect more than 159 specific intracellular signaling pathways...

January 2015
FROM
Global Prostate Cancer Epidemiology and Patient Flow Analysis - 2015 Global Prostate Cancer Epidemiology and Patient Flow Analysis - 2015 - Product Thumbnail Image

Global Prostate Cancer Epidemiology and Patient Flow Analysis - 2015

The author announced the results of its Prostate Cancer patient population study in a new report ‘Global Prostate Cancer Epidemiology and Patient Flow Analysis - 2015’. The report provides insights...

January 2015
FROM
Global Gastric Cancer Epidemiology and Patient Flow Analysis - 2015 Global Gastric Cancer Epidemiology and Patient Flow Analysis - 2015 - Product Thumbnail Image

Global Gastric Cancer Epidemiology and Patient Flow Analysis - 2015

The author announced the results of its Gastric Cancer patient population study in a new report ‘Global Gastric Cancer Epidemiology and Patient Flow Analysis - 2015’. The report provides insights into...

January 2015
FROM
Global Cervical Cancer Epidemiology and Patient Flow Analysis - 2015 Global Cervical Cancer Epidemiology and Patient Flow Analysis - 2015 - Product Thumbnail Image

Global Cervical Cancer Epidemiology and Patient Flow Analysis - 2015

The author announced the results of its Cervical Cancer patient population study in a new report ‘Global Cervical Cancer Epidemiology and Patient Flow Analysis - 2015’. The report provides insights...

January 2015
FROM
Global Head and Neck Cancer Epidemiology and Patient Flow Analysis - 2015 Global Head and Neck Cancer Epidemiology and Patient Flow Analysis - 2015 - Product Thumbnail Image

Global Head and Neck Cancer Epidemiology and Patient Flow Analysis - 2015

The author announced the results of its Head and Neck Cancer patient population study in a new report ‘Global Head and Neck Cancer Epidemiology and Patient Flow Analysis - 2015’. The report provides...

January 2015
FROM
Global Bladder Cancer Epidemiology and Patient Flow Analysis - 2015 Global Bladder Cancer Epidemiology and Patient Flow Analysis - 2015 - Product Thumbnail Image

Global Bladder Cancer Epidemiology and Patient Flow Analysis - 2015

The author announced the results of its Bladder Cancer patient population study in a new report ‘Global Bladder Cancer Epidemiology and Patient Flow Analysis - 2015’. The report provides insights into...

January 2015
FROM
Global Ovarian Cancer Epidemiology and Patient Flow Analysis - 2015 Global Ovarian Cancer Epidemiology and Patient Flow Analysis - 2015 - Product Thumbnail Image

Global Ovarian Cancer Epidemiology and Patient Flow Analysis - 2015

The author announced the results of its Ovarian Cancer patient population study in a new report ‘Global Ovarian Cancer Epidemiology and Patient Flow Analysis - 2015’. The report provides insights into...

January 2015
FROM
Global Breast Cancer Epidemiology and Patient Flow Analysis - 2015 Global Breast Cancer Epidemiology and Patient Flow Analysis - 2015 - Product Thumbnail Image

Global Breast Cancer Epidemiology and Patient Flow Analysis - 2015

The author announced the results of its Breast Cancer patient population study in a new report ‘Global Breast Cancer Epidemiology and Patient Flow Analysis - 2015’. The report provides insights into...

January 2015
FROM
2015 Global Cancer Market Overview: Facilities, Test Volumes, and Sales Forecasts by Country 2015 Global Cancer Market Overview: Facilities, Test Volumes, and Sales Forecasts by Country - Product Thumbnail Image

2015 Global Cancer Market Overview: Facilities, Test Volumes, and Sales Forecasts by Country

This report provides a worldwide overview of the cancer diagnostics market, including mortality statistics and scientific views on the etiology of major types of cancer, estimates of the number of laboratories...

January 2015
FROM
2015 World Cancer Diagnostics Market Key Players: Strategic Assessments of Major Suppliers and Emerging Market Entrants 2015 World Cancer Diagnostics Market Key Players: Strategic Assessments of Major Suppliers and Emerging Market Entrants - Product Thumbnail Image

2015 World Cancer Diagnostics Market Key Players: Strategic Assessments of Major Suppliers and Emerging Market Entrants

This report presents strategic analyses of major current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product portfolios, distribution tactics, technological...

January 2015
FROM
Fierce 15 in Oncology Drug Pipeline Update 2015 Fierce 15 in Oncology Drug Pipeline Update 2015 - Product Thumbnail Image

Fierce 15 in Oncology Drug Pipeline Update 2015

The prestigious Fierce 15 biotech award has come to symbolize novelty and being at the forefront of biotechnology development amongst privately held businesses. The winners of this award are aiming...

January 2015
FROM
CAR-T Therapies in Oncology Drug Pipeline Update 2015 CAR-T Therapies in Oncology Drug Pipeline Update 2015 - Product Thumbnail Image

CAR-T Therapies in Oncology Drug Pipeline Update 2015

Chimeric antigen receptors (CARs) are a game changer within cancer therapies and there will be a place in history and huge recognition for any company which is able to launch the first successful CAR-T...

January 2015
FROM
Loading Indicator

Our Clients

Photocure ASA Roche Diagnostics Ltd. Abbott Laboratories Ltd. Pfizer, Inc. Novartis AG Becton, Dickinson and Company (BD)